In this handout photo released by Gamaleya Scientific Research Institute of Epidemiology and Microbiology, a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology is pictured in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as the two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Editorial use only, no archive, no commercial use.

10.03.2021#6484837

In this handout photo released by Gamaleya Scientific Research Institute of Epidemiology and Microbiology, a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology is pictured in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as the two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Editorial use only, no archive, no commercial use.

10.03.2021#6484836

In this handout photo released by Gamaleya Scientific Research Institute of Epidemiology and Microbiology, a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology is pictured in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as the two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Editorial use only, no archive, no commercial use.

10.03.2021#6484835

In this handout photo released by Russian Direct Investment Fund, a person is being inoculated with Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476833

In this handout photo released by Russian Direct Investment Fund, a person is being inoculated with Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476831

In this handout photo released by Russian Direct Investment Fund, a medical worker holds a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476712

In this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476707

In this handout photo released by Russian Direct Investment Fund, a medical worker opens the fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476704

In this handout photo released by Russian Direct Investment Fund, a medical worker fills a syringe with Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476697

In this handout photo released by Russian Direct Investment Fund, a medical worker holds a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476690

In this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476685

In this handout photo released by Russian Direct Investment Fund, a medical worker holds a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476682

In this handout photo released by Russian Direct Investment Fund, a view shows a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.

02.03.2021#6476680